HRT Financial’s Sonoma Pharmaceuticals SNOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22K Buy
+17,493
New +$22K ﹤0.01% 4483
2025
Q2
– Sell
-11,843
Closed -$25K – 3453
2025
Q1
$25K Buy
+11,843
New +$32K ﹤0.01% 2286
2024
Q3
– Sell
-1,076
Closed -$4K – 3078
2024
Q2
$4K Buy
+1,076
New +$3.83K ﹤0.01% 2054
2024
Q1
– Sell
-1,393
Closed -$5K – 3038
2023
Q4
$5K Buy
+1,393
New +$8.88K ﹤0.01% 2132

Other funds holding SNOA

HRT Financial's SNOA Position: Q3 2026 in Review

HRT Financial opened a new position in Sonoma Pharmaceuticals (SNOA) in Q3 2026: 17,493 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #4483 among its holdings. This is a return to the name: HRT Financial previously reported a position in SNOA as recently as Q1 2025.

HRT Financial first reported a position in SNOA in Q4 2023 and has held it in 4 quarters since. The position peaked at $25K in Q1 2025. 15 funds tracked by Wall St. Rank hold SNOA as of Q3 2026.

  • HRT Financial held 17,493 shares of Sonoma Pharmaceuticals worth $22K as of Q3 2026.
  • Sonoma Pharmaceuticals was a new HRT Financial position in Q3 2026.
  • Sonoma Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4483 holding.
  • HRT Financial first reported a position in Sonoma Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • HRT Financial's Sonoma Pharmaceuticals position peaked at $25K in Q1 2025.
  • 15 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.